Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion type Assertion NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_head.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion description "[Platelet function tests with arachidonic acid (ARA) and urinary 11-dehydro-thromboxane B2 (11-DH-TXB2) concentrations were performed in 262 patients with unstable coronary artery disease who had not been taking aspirin before admission.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_provenance.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion evidence source_evidence_literature NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_provenance.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion SIO_000772 21740787 NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_provenance.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion wasDerivedFrom befree-20140225 NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_provenance.
- NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_assertion wasGeneratedBy ECO_0000203 NP501706.RAQc9kj6LpV97Kb-Mhr46UT-UH17pKUlLc9Qr446Lm8Ik130_provenance.